We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
+43.57%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
–
AUM
$161M
AUM Growth
+$9.16M
Cap. Flow
-$327K
Cap. Flow %
-0.2%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
SGMT icon
Sagimet Biosciences
SGMT
+$123K

Top Sells

Rank Stock Value
1
ORIC icon
Oric Pharmaceuticals
ORIC
+$325K
2
SRZN icon
Surrozen
SRZN
+$124K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNYA icon
1
Tenaya Therapeutics
TNYA
$163M
$49.2M 30.62%
9,400,290
– –
ORIC icon
2
Oric Pharmaceuticals
ORIC
$1.44B
$48.7M 30.33%
3,540,777
-27,404
-0.8% -$325K
NGM
3
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$28.8M 17.96%
18,136,735
– –
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
$24.1M 14.99%
335,078
– –
SRZN icon
5
Surrozen
SRZN
$282M
$9.69M 6.03%
616,540
-11,111
-2% -$124K
SGMT icon
6
Sagimet Biosciences
SGMT
$656M
$93.1K 0.06%
+17,169
New +$123K
RVMD icon
7
Revolution Medicines
RVMD
$43.7B
$1.48K ﹤0.01%
46
– –

Similar funds

PIS
POM Investment Strategies Raleigh, North Carolina $88.3M AUM 15.23% 1-Year Est. Return
FWM
FSR Wealth Management Elmhurst, Illinois $87.8M AUM 10.63% 1-Year Est. Return
WP
Walleye Partners Madison, Wisconsin $87.7M AUM
SHCM
Stone House Capital Management Bay Harbor Islands, Florida $88.5M AUM 149.16% 1-Year Est. Return
YIM
Yoffe Investment Management Lemoyne, Pennsylvania $87.4M AUM 30.8% 1-Year Est. Return
VPW
Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return
LC
Luminist Capital Grand Rapids, Michigan $89M AUM 17.66% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Column Group's Q1 2024 Portfolio in Review

As of Q1 2024, Column Group held 7 positions worth $161M, up 6.1% from $151M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Column Group's Q1 2024 filing shows 1 new and 2 reduced positions. Its largest new stake was Sagimet Biosciences: 17,169 shares worth $93.1K. The largest sale was Oric Pharmaceuticals, an estimated $325K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Column Group's largest Q1 2024 buy was Sagimet Biosciences: 17,169 shares worth $93.1K.
  • Column Group's biggest Q1 2024 reduction was Oric Pharmaceuticals, cutting an estimated $325K.
  • Column Group's ten largest holdings make up 100% of its $161M portfolio in Q1 2024.
  • Column Group opened 1 new position and closed 0 in Q1 2024.
  • Column Group's portfolio value rose 6.1% quarter-over-quarter to $161M.

Based on Column Group's 13F filing for Q1 2024, filed 15 May 2024.